OVER a period of 15 
cancer in man, critically reviewed by Gruschko (1961) , provides the rationale for examining chromium-containing compounds for carcinogenicity. If certain industrial processes could be pin-pointed as especially hazardous, it would be possible to direct protective meas-ares, currently being taken in all sectors, to those parts of the process which appear to be more likely to be associated with the risk of lung cancer. This might have the advantage to the industry of reducing the cost of ensuring that the risk is eliminated. Calcium chromate is formed in varying amounts when chromite ore is heated with limestone and sodium or potassium carbonate-the first step in processing the crude ore-and this would appear to be one important stage where potential carcinogens might be encountered.
The present findings should be considered alongisde those of Laskin and his colleagues who, at the meeting of the American Industrial Health Association in St. Louis in May 1968, reported the induction of squamous carcinomas of the lung in 6, and adenocarcinomas of the lung in 2, out of 100 rats exposed to calcium chromate in the form of a pellet attached to the bronchial mucosa. The injection sites in the 6 test rats which did not develop local tumours, and in the 16 control animals injected with arachis oil alone, showed no specific features. There was no epidermal ulceration. The dermis contained increased amounts of fibrous tissue, infiltrates of macrophages and chronic inflammatory cells, and dilated lymphatic vessels. These changes were more prominent in rats injected with calcium chromate than in rats which were given arachis oil only.
No distant tumours developed in any rats in the test or control groups. Some animals from both groups showed bronchiectasis and cystic nephritis (sometimes accompanied by hydronephrosis) but there was no difference in the incidence, extent, or severity of these lesions between the test and control groups.
DISCUSSION
In 1827, Cumin described ulcers and sloughs " of a peculiarly penetrating character " on the hands and forearms of Scottish workers who handled " bichromate of potass ". Similar cutaneous lesions were observed by later writers and perforating septal ulcers of the nose were reported in chromate workers by Delpech and Hillairet in 1869 (see Gafafer, 1952) . Neither of these lesions was pre-neoplastic, no damage to other tissues following exposure to chromiumcontaining compounds was noted, and it was not until the 1930's that an association between exposure to chromates and the development of malignant diseaselung cancer-was suspected. German investigators (see reviews by Machle and Gregorius, 1948; Baetjer, 1950; Gafafer, 1952) were the first to recognise this association but their data were inadequate to calculate the risk involved; furthermore, the diagnosis of lung cancer was not always firmly established and some patients had been exposed to other known carcinogens. Machle and Gregorius (1948) conducted a survey of chromate workers in the United States and reported an exceptionally high risk of lung cancer in men engaged in the production of chromates and, to a lesser extent, of chrome pigments. No increase in cancer of other sites was found. Despite certain criticisms of the design of Machle and Gregorius's study, Baetjer (1950) confirmed their final conclusion and showed that lung cancer was not only more common but also occurred earlier in the chromate workers, the highest incidence being found in the [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] Hueper (1955) reported essentially negative results in a series of investigations in which various species were exposed to powdered chromium ore or to pure powdered metallic chromium, administered by various routes. In 1958, Hueper reported a small number of malignant tumours developing in rats after intramuscular or intrapleural administration of chromite ore roast. He stressed that the yield of neoplasms was small and that chromite ore contained other putative carcinogens as well as chromium; but in an addendum to this paper, he noted that calcium chromate implanted intramuscularly in rats produced local sarcomas. This observation was extended in a later paper (Hueper and Payne, 1959) , in which it was shown that intramuscular implantation of calcium chromate or chromium trioxide in rats was followed by local tumours in 60-79% of animals. Calcium chromate was subsequently found to induce injection-site sarcomas in mice (Payne, 1960) but attempts to produce pulmonary tumours in rats by intratracheal administration of calcium chromate were unsuccessful (Hueper and Payne, 1962) .
The present findings constitute a complete and independent confirmation of those of Hueper and Payne (1959) in respect of the potent carcinogenicity of calcium chromate for the subcutaneous tissues of the rat. As such, they may serve as a pointer to those concerned with the lung cancer hazard in the chromateproducing industry. The induction of pulmonary cancers in rats by the intrabronchial implantation of pellets containing calcium chromate or chromic chromate by Laskin and his colleagues (see introduction) may serve the same purpose. SUMMARY Twenty-four young male CB stock rats received 20 once-weekly injections of calcium chromate, suspended in 0-2 ml. arachis oil, given intramuscularly into the right flank; each rat received 19 mg. calcium chromate. Sixteen similar control rats received 20 once-weekly intramuscular injections of 0-2 ml. arachis oil alone. The experiment was terminated after 63 weeks when the surviving animals were killed.
Spindle cell and pleomorphic cell sarcomas developed at the site of injection in 18 of the 24 test rats (75%/). The first tumour appeared 203 days after the beginning of the experiment and the mean period of induction was 323 days. The tumours were locally invasive but did not metastasise. No neoplasms were found at other sites and no injection-site tumours developed in control rats which received arachis oil alone.
These observations confirm the previous account by Hueper and Payne (1959) and indicate that calcium chromate is a potent carcinogen for the subcutaneous tissues of the rat. The present findings, particularly when taken in conjunction with the recent report by Laskin and his colleagues of lung cancers induced in rats with intrabronchial pellets of calcium chromate, indicate that this compound may be at least one of the carcinogens responsible for the well-documented cancer-hazard associated with the chromate-producing industry.
